Methods: We conducted a retrospective survey of 7132 Iranian renal transplant recipients to find those with Mucormycosis in eight transplant centers from January 1990 to June 2008. A total of 22 patients had received kidneys from living donors were complicated with Mucormycosis. Mean follow up period after diagnosis was 9±13(1-60) months.

 Results: No significant differences were found between infection occurrence and gender (P=0.6). Patients with mucormycosis were older than those who had no infection (p=0.02) with the mean age at diagnosis 48 ± 13 years. The diagnosis time since transplantation ranged from 1-84 (Median: 12) months. Mucormycosis was most likely to occur within 1 year after renal transplantation (n=13). The major form of disease in population studied was rhino-cerebral (n =11), followed by pulmonary (n=8), cutaneous (n=2), and disseminated (n=1). In addition, 9 patients have had the history of steroid pulse therapy. Diabetes mellitus was seen in 6 recipients with mucormycosis.

Conclusions: To our knowledge, the current study is the largest sample of renal recipients with ormycosis in living donor renal transplantation. Augmented immunosuppression, especially with corticosteroids, older age and PTDM were the predisposing factors for the infection.

Methods: We conducted a retrospective survey of 7132 Iranian renal transplant recipients to find those with Mucormycosis in eight transplant centers from January 1990 to June 2008. A total of 22 patients had received kidneys from living donors were complicated with Mucormycosis. Mean follow up period after diagnosis was 9±13(1-60) months.

 Results: No significant differences were found between infection occurrence and gender (P=0.6). Patients with mucormycosis were older than those who had no infection (p=0.02) with the mean age at diagnosis 48 ± 13 years. The diagnosis time since transplantation ranged from 1-84 (Median: 12) months. Mucormycosis was most likely to occur within 1 year after renal transplantation (n=13). The major form of disease in population studied was rhino-cerebral (n =11), followed by pulmonary (n=8), cutaneous (n=2), and disseminated (n=1). In addition, 9 patients have had the history of steroid pulse therapy. Diabetes mellitus was seen in 6 recipients with mucormycosis.

Conclusions: To our knowledge, the current study is the largest sample of renal recipients with ormycosis in living donor renal transplantation. Augmented immunosuppression, especially with corticosteroids, older age and PTDM were the predisposing factors for the infection.

Nephro-Urology Monthly

CiteScore 2019 : 1.6

SIGN IN REGISTER SUPPORT

Home

Articles

All Issues Current Issue In Press Accepted Manuscripts

Instructions

About Journal

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR) Publication Ethics and Publication Malpractice Statement Contact Us

Pricing

SEARCH

Mucormycosis after Living Donor Kidney Transplantation: A Multicenter Retrospective Study

AUTHORS

Pedram Ahmadpour ¹ , Mahboob Lessan Pezeshki ¹ , Mohammad Hassan Ghadiani ^, , Fatemeh PourReza Gholi ¹ , Fariba Samadian ¹ , Jafar Aslani ¹ , Heshmatollah Shahbazian ² , Mohammad Reza Ghanj ¹ , Ammir Hossein Miladipour ¹ , Nader Nouri Majalan ³

1 Department of Nephrology, Shahid Beheshti University of Medical Sciences, Iran

2 Department of Nephrology, Ahwaz University of Medical Sciences, Iran

3 Department of Nephrology, Yazd University of Medical Sciences, Iran

How to Cite: Ahmadpour P, Pezeshki M, Ghadiani M, Gholi F, Samadian F, et al. Mucormycosis after Living Donor Kidney Transplantation: A Multicenter Retrospective Study, Nephro-Urol Mon. Online ahead of Print ; 1(1):39-43.

ARTICLE INFORMATION

Nephro-Urology Monthly: 1 (1); 39-43

Article Type: Research Article

Received: March 10, 2009

Accepted: April 12, 2009

READ FULL TEXT

Abstract

Background and Aims: Mucormycosis is an extremely rare and potentially fatal complication after kidney transplantation. Limited data are available on mucormycosis following living donor kidney transplantation. The aim of this study was to determine the incidence of mucormycosis and to identify the clinical presentation and mortality rate in renal allograft recipients.

Methods: We conducted a retrospective survey of 7132 Iranian renal transplant recipients to find those with Mucormycosis in eight transplant centers from January 1990 to June 2008. A total of 22 patients had received kidneys from living donors were complicated with Mucormycosis. Mean follow up period after diagnosis was 9±13(1-60) months.

 Results: No significant differences were found between infection occurrence and gender (P=0.6). Patients with mucormycosis were older than those who had no infection (p=0.02) with the mean age at diagnosis 48 ± 13 years. The diagnosis time since transplantation ranged from 1-84 (Median: 12) months. Mucormycosis was most likely to occur within 1 year after renal transplantation (n=13). The major form of disease in population studied was rhino-cerebral (n =11), followed by pulmonary (n=8), cutaneous (n=2), and disseminated (n=1). In addition, 9 patients have had the history of steroid pulse therapy. Diabetes mellitus was seen in 6 recipients with mucormycosis.

Conclusions: To our knowledge, the current study is the largest sample of renal recipients with ormycosis in living donor renal transplantation. Augmented immunosuppression, especially with corticosteroids, older age and PTDM were the predisposing factors for the infection.

Keywords

Mucormycosis Renal Transplantation Living Donor Multicenter Study

Full Text

Full text is available in PDF

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

COMMENTS

LEAVE A COMMENT HERE: